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Abstract: The chemical synthesis by solid-phase methods of a novel amphiphilic peptide, peptide-conjugate amphiphile
(PCA), containing in the same molecule three different functions: (i) the N ,N-bis[2-[bis(carboxy-ethyl)amino]ethyl]-L-glutamic
acid (DTPAGlu) chelating agent, (ii) the CCK8 bioactive peptide, and (iii) a hydrophobic moiety containing four alkyl chains
with 18 carbon atoms each, is reported. In water solution at pH 7.4, PCA self-assembles in very stable micelles at very low
concentration [critical micellar concentration (cmc) values of 5 × 10−7 mol kg−1] as confirmed by fluorescence spectroscopy. The
structural characterization, obtained with small-angle neutron scattering (SANS) measurements, indicates that the aggregates
are substantially represented by ellipsoidal micelles with an aggregation number of 39 ± 2 and the two micellar axes of about 52
and 26 A˚. Copyright  2008 European Peptide Society and John Wiley & Sons, Ltd.
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INTRODUCTION
During the past years, several supramolecular aggre-
gates, such as micelles, vesicles and liposomes, con-
taining a high number of stable gadolinium(III) com-
plexes and derivatized on their external surface with
bioactive molecules (peptides or antibodies) have been
proposed as target selective contrast agents in mag-
netic resonance imaging (MRI) [1–4]. An ideal target
selective MRI contrast agent should increase the signal
intensity at the target site and in the meantime should
lower the signal intensity in the vascular space, so as to
eliminate the disadvantageous value of the background,
giving well-solved images of the cellular target and of
the surrounding tissues [5].
On this topic, we developed a first example of mixed
micelles containing a large number of gadolinium
complexes and bioactive peptides, conjugated to C18
single-chain hydrophobic moieties. These aggregates
present a spherical shape with a diameter in the range
of 70–80 A˚. They were characterized by high relaxivity,
due to the large number of paramagnetic gadolinium
complexes, and by target specificity due to the bioactive
peptide [6].
More recently, we reported the synthesis, the struc-
tural characterization and the relaxometric behavior
of a new monomer with an ‘upsilon’ shape (MonY) in
which a lysine residue is derivatized on its three reactive
functions with: the chelating agent DTPAGlu(N ,N-bis[2-
[bis(carboxyethyl)amino]ethyl]-L-glutamic acid), a DTPA
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derivative able to give very stable complex of Gd(III)
ions; the bioactive C-terminal octapeptide of chole-
cystokinin (CCK8) able to give receptor recognition;
and a hydrophobic moiety containing two alkyl chains
with 18 carbon atoms each. As indicated by dynamic
light scattering (DLS) and small-angle neutron scatter-
ing (SANS) measurements, MonY, and its gadolinium
complex MonY(Gd), aggregates in water solution giving
ellipsoidal micelles with the ratio between the micel-
lar axis of ∼1.7 and the aggregation number Nagg of
∼30. Self-assembling micelles of MonY(Gd) present high
relaxivity values (r1p = 15.03 mM−1s−1) for each gadolin-
ium complex in the aggregate and could be considered
as new promising selective MRI contrast agents [7].
Although in this latter monomer, the hydrophobic
moiety is represented by two long hydrocarbon chains
(18 carbon atoms each) vesicular aggregates have not
been detected by structural characterization. A plausi-
ble explication can be found in the well-known empirical
model developed by Ninham and coworkers [8] to pre-
dict aggregate type based on the steric relationship of
head-group and side-arm size. A surfactant parame-
ter, P = v/až l, was proposed (a is head-group surface
area, v and l are the volume and length of the side
chains) to predict the aggregation behavior in solution.
A value 0.5 < P < 1 predicts vesicles and P < 0.5 pre-
dicts micelle formation. To favor vesicular aggregation
the head-group surface area (a parameter) should be
decreased or the volume of the hydrophobic moiety
(v parameter) should be increased. In any case, the
first one cannot be modified because both functions
(chelating agent and bioactive peptide) are crucial for
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the complex and to address gadolinium ions to the bio-
logical target. Then, the only part of the molecule that
can be re-designed is the hydrophobic moiety.
In this article, we report, as natural evolution of
the previously described compounds, the synthesis in
solid-phase and the characterization of a novel peptide-
conjugate amphiphile (PCA) in which the hydrophobic
moiety is formed by four hydrocarbon tails with 18
carbon atoms, while the hydrophilic head still contains
the DTPAGlu chelating agent and the CCK8 bioactive
peptide (Figure 1). The structural characterization, by
SANS and fluorescence spectroscopy of the resulting
supramolecular aggregates is reported.
RESULTS AND DISCUSSION
Monomer Synthesis
The PCA was synthesized by solid-phase meth-
ods using the Rink-amide 4-methylbenzhydrylamine
(MBHA) resin as polymeric support and the Fmoc/tBu
chemistry. The CCK8 peptide was synthesized accord-
ing to standard SPPS protocols [9]. At the Asp N-
terminal residue of the CCK8 peptide, a glycine residue
and five units of 8-amino-3,6-dioxaoctanoic acid, act-
ing as spacers, were consecutively added. The five
ethoxylic spacers were introduced in order to increase
the hydrophilicity of the CCK8 peptide and to improve
the exposition of the peptide on the external surface
of the aggregate. The synthesis of the asymmetric pep-
tidic compound was carried out by the introduction of
two orthogonally protected amino acids: Fmoc-Lys(Mtt)-
OH and Fmoc-Asp-ODmab. The scheme of synthesis is
briefly reported in Figure 2. After the Fmoc protecting
group removal from the last ethoxylic spacer, the Fmoc-
Lys(Mtt)-OH residue was condensed on the primary
chain of the peptide derivative; the N-4-methyltrityl
(Mtt) protecting group was removed in a selective way
in acido-labile conditions. On the lysine side chain a
Fmoc-Asp-ODmab residue was condensed. The Dmab
group was removed using brief treatment with 2%
hydrazine in DMF, giving the free acid [10]; then,
DTPALys-pentaester was condensed by activating the
aspartic carboxylic function with HATU. The four alkyl
chains were introduced in one step at the N-terminal
end, after removing the two Fmoc groups from the
primary chains. The crude product was obtained by
using standard cleavage procedure; anyway, reaction
time was prolonged up to 12 h to allow complete
removal of protecting groups from the carboxylic func-
tions present on the DTPALys chelating agent. After
RP-HPLC purification on C4 column, the desired com-
pound was obtained at HPLC purity higher than 95%
in 10% yield. The self-assembling behavior of the PCA
monomer was evidenced by critical micellar concen-
tration (cmc) measured using fluorescence and SANS
measurements.
Structural Characterization
Fluorescence studies. The 8-anilino-1-napthalene sul-
fonic acid ammonium salt (ANS) is one of the most
frequently used fluorescence probe to determine the
relative hydrophobicities of the binding sites in a num-
ber of proteins and to detect the protein conformational
changes induced by ligand binding [11]. The properties
of ANS fluorescence, such as quantum yield, lifetime,
and position of fluorescence maximum, are sensitive to
the polarity of the immediate environment surrounding
the probe (the micropolarity). In solution, surfactants
and dyes can interact and form micellar complexes
which have characteristic features [12–14]. ANS is an
anionic probe which is essentially nonfluorescent in
water, but highly fluorescent in nonpolar environments
or macromolecules (micelles) [14]. Its wavelength of
maximum fluorescence intensity varies with its envi-
ronment, but usually occurs between 450 and 480 nm.
In aqueous solutions, ANS is almost nonfluorescent.
The addition of the amphiphilic surfactant, to the
aqueous ANS solution caused an increase in the fluo-
rescence intensity, which reaches a plateau at higher
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Figure 1 Schematic representation of (C18)4-(Asp(DTPALys))Lys-L5-G-CCK8 (PCA). The amino acid sequence of CCK8 peptide
is reported by using the one-letter amino acid code.
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CCK8-Gly-(AdOO)5-Fmoc
1) DMF/ Pip (80/20)
2) Fmoc-Lys(Mtt)-OH
PyBop, HOBt, DIEA
1) DCM/TIS/TFA (94/5/1)
2) Fmoc-Asp-ODmab
PyBop, HOBt, DIEA
CCK8-Gly-(AdOO)5-Lys(Mtt)-Fmoc
CCK8-Gly-(AdOO)5-Lys-Fmoc
ODmab-Asp-Fmoc
1) DMF/ Hydrazine (98/2)
2) H2N-DTPALys(OtBu)5
HATU, DIEA
CCK8-Gly-(AdOO)5-Lys-Fmoc
DTPALys(OtBu)5-Asp-Fmoc
2) N,N Dioxaoctanoic acid
PyBop, HOBt, DIEA
1) DMF/ Pip (80/20)
3) TFA/TIS/H2O
CCK8-Gly-(AdOO)5-Lys-NHCO-CH2CH2CO-N
DTPALys-Asp-NHCOCH2CH2CO-N
(CH2)17-CH3
(CH2)17-CH3
(CH2)17-CH3
(CH2)17-CH3
Figure 2 Peptide synthesis, reagents and conditions according to the Fmoc solid-phase protocol. Wang resin is schematically
represented as an empty circle.
concentrations. The plateau indicates that all the dye is
interacting with the surfactant micelles and occurs at
only at sufficiently high concentrations of surfactant.
The experimental measure of the ANS fluorescence
intensity at 480 nm, corresponding to the maximum of
spectrum, on the function of the PCA concentration,
provides the cmc. The break-point in Figure 3(a)
indicates a cmc value of 5 × 10−7 mol kg−1 that confirms
the high stability of the resulting supramolecular
aggregates. As expected, this value is much lower than
those found for mixed aggregates in which monomers
contain only one C18 tail (5 × 10−5 mol kg−1) [6]
and slightly lower than that found for self-assembling
aggregates of MonY monomer in which the monomeric
molecule contains two C18 tails in the hydrophobic
region (8 × 10−7 mol kg−1) [7]. The high tendency of
PCA monomer to self-assemble in water solution at
low concentration can be ascribed to the presence of
four C18 hydrocarbon tails for each monomer; the
hydrocarbon tails strongly interact forming a well-
stabilized hydrophobic inner region.
Aggregation number of surfactants into the micelles
is generally evaluated by fluorescence quenching of
pyrene. In the present case, having in the sequence of
the PCA a Trp residue, electron transfer phenomena
between pyrene and Trp indole side chains can occur
[15]. Recently, a new method had been reported to
evaluate the aggregation number by starting from the
ANS fluorescence behavior in a surfactant solution [16].
The validity of this method is demonstrated by the
similar value of the aggregation numbers obtained to
those that have been reported in literature. It is based
on the assumption that ANS dye interacts with the
micelle, forming a complex, with a well-defined constant
KM :
KM = FMAX − F0[Dcomplex ] (1)
Where [Dcomplex] is the concentration of the dye in the
complex form, FMAX and F0 are the maximum and initial
fluorescence intensities, respectively. The F values at
any value other than FMAX can be related similarly to
the complexed dye [D1complex] as:
KM = F − F0
[D1complex ]
(2)
By combining Eqns (1) and (2), the following equation
is obtained:
Fr = F − F0
FMAX − F0 =
D1complex
Dcomplex
(3)
In accordance with the complexation equilibrium in
the excited state of ANS, the fluorescence intensity can
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Figure 3 (a) Fluorescence intensity of ANS fluorophore at
480 nm versus PCA concentration. The cmc value of 5 × 10−7
mol kg−1 is established from graphical break-point; (b) The
linear plots of 1/(1 − Fr) versus [ANS]/Fr; (c) fluorescence
spectrum of tryptophan residue in 1.0 · 10−4 M PCA. The
spectrum was excited at 280 nm.
be used to evaluate KM . On the basis of Eqns 1 to 3,
the equilibrium constant is given by:
1
1 − Fr =
KM
Nagg
[S]
Fr
− KM [ANS] (4)
The linear plots of 1/(1 − Fr) versus [ANS]/Fr is
reported in Figure 3(b). The values of binding constant
KM and aggregation number Nagg are determined from
the slope and intercept of the linear plot.
The aggregation number was found to be 38. This
result is in good agreement with the aggregation
number calculated by SANS measurement (see below).
The fluorescence spectroscopy was also utilized to
localize the position of the CCK8 peptide moiety in the
aggregate. The presence of a fluorescence maximum
at 354 nm, diagnostic of the hydrophilic environment
of the indole group on tryptophan side chain [17],
confirms the well-exposition of the peptide on the
hydrophilic external shell of the micelle (Figure 3(c)).
This result suggests the use of the CCK8 peptide to
drive the entire aggregate toward CCK receptors present
on cell membranes.
Small-angle neutron scattering. SANS measurements
have been carried out on binary system PCA/D2O.
The collected data are reported in Figure 4, where in
order to make the discussion of the results easier, data
have been multiplied for a scale factor, as specified.
Inspection of the data reveals the presence of a typical
form factor of scattering aggregates, i.e. spherical or
ellipsoidal micelles, with weak or negligible interactions.
The scattering cross section d/d of a collection of
monodisperse bodies is described by the equation [18].
d
d
= npP(q)S(q) +
(
d
d
)
incoh
(5)
where np is the number density of scattering bodies,
P(q) and S(q) are the form factor and the structure
factor of the bodies, respectively, while (d/d)inch is
the incoherent scattering cross section, mainly due
to the presence of hydrogen atoms in the molecules
studied. The form factor P(q) contains information on
the shape of the scattering objects, while the structure
factor S(q) accounts for interparticle correlations and
is normally important for concentrated or charged
systems. Provided that the solutions are quite dilute,
the structure function S(q) can be approximated to
unity, and the scattering cross section is reduced to
d
d
= npP(q) +
(
d
d
)
incoh
(6)
In order to extract quantitative information from the
scattering data, the system has been modeled as a
collection of ellipsoids with an inner core and an outer
shell having two different scattering length densities, ρ1
and ρ2 respectively. If the three main semiaxis of the
inner core are labeled a = b = c and δ is the outer shell
thickness, the form factor can be written as [19].
P(q) =
∫ 1
0
[
4
3
πab2(ρ1 − ρ2)3j1(u1)u1
+4
3
π(a + δ)(b + δ)2(ρ2 − ρ0)3j1(u2)u2
]
dµ (7)
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where ρ0 is the solvent scattering length density, and
u1 = q
√
a2µ2 + (1 − µ2)b2 (8)
u2 = q
√
(a + δ)2µ2 + (1 − µ2)(b + δ)2 (9)
whereas j1(x) = (sin x − x cos x)/x2 is the spherical
Bessel function of the first kind. By fitting Eqn 6
to 9 to the experimental data, it has been possible to
get information about the micellar aggregates, treating
the parameters a, b and δ as unknown parameters.
Information on the aggregation number Nagg has also
been obtained by the equation Nagg = 4πab2/(3νsurf)
where νsurf is the volume of a surfactant molecule.
The scattering profile reported in Figure 4 suggests
that the aggregates present in the systems are low-
charged objects and no evidence of interaction peak
is present in I(q) versus q, as expected for charged
aggregates. From the structural point of view, the
system contains oblate micelles that do not show a
growth in their size upon concentration increase, see
Table 1. The slight increase of the scattering intensity
from 0.86 to 1.02 cm−1 at q = 0, when the concentration
is raised, probably just reflects the increase of the
micelles density.
It is interesting to highlight that, notwithstanding the
presence of four hydrophobic tails for each monomer,
PCA monomers form oblate micelles with a growth along
the b, and c axes instead of the expected bilayers or
vesicles. This result can be explained by calculating
the packing factor P (P = 0.13) which is still below
the 0.50 value. Anyway, the oblate micelles are larger
aggregates with respect to that previously observed, as
clearly indicated in Figure 5. Accordingly, the packing
factor scales up from one to four hydrophobic chains
systems.
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Figure 4 Scattering cross sections obtained at 25 °C for
the following systems: ž PCA (0.25 mmol kg−1) − D2O
°
PCA
(0.50 mmol kg−1) − D2O Fitting curves to the experimental
data through the models reported in the text are reported.
For a better comparison, data have been multiplied for a scale
factor as indicated in the plot.
Table 1 Fitting parameters obtained from SANS data at 25 °C
for the PCA system through the equations reported in the text.
The table displays the concentration of the solute, the three
main semiaxis of the micellar hydrophobic core (a,b and c), the
thickness of the micellar hydrophilic shell δ, and the micellar
aggregation number Nagg
CPCA
mmol kg−1
a
A˚
b
A˚
= c
A˚
δ
A˚
Nagg
0.25 11.4 ± 1.2 38.3 ± 1.0 14.8 ± 0.4 39 ± 2
0.50 11.9 ± 1.4 37.7 ± 1.0 15.1 ± 0.4 39 ± 2
= C18DTPAGlu
= C18CCK8 =MonYLys
Lys 
=PCA
Asp 
a = 9 Å
b = c = 27Å
δ = 15 Å
P = 0.06
a = 12 Å
b = c = 38 Å
δ = 15 Å
P = 0.13
a = b = 17Å
δ = 18 Å
P = 0.052
 
a=b
δ
 
b=c
a
δ
 
b=c
a
δ
Figure 5 Schematic view of different micellar aggregates with the geometrical parameters: (a) spherical micelles obtained
by co-aggregation of monomers bearing a single C18 hydrocarbon tail; (b) ellipsoidal micelles obtained by self-aggregation of
monomers bearing a double C18 tail (MonY); (c) ellipsoidal micelles obtained by self-aggregation of the four C18 tails PCA
monomers.
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CONCLUSIONS
In this article, we have reported the synthesis and
the structural characterization of a novel amphiphilic
monomer (PCA) containing in the same molecule three
different functions: (i) the DTPAGlu chelating agent,
(ii) the CCK8 bioactive peptide able to give receptor
recognition, and (iii) a hydrophobic moiety containing
four alkyl chains with 18 carbon atoms each. In water
solution at pH 7.4, the PCA self-assembles at very low
concentration as confirmed by fluorescence and SANS
measurements. The aggregates are substantially repre-
sented by ellipsoidal micelles in which the ratio between
the micellar axis is ∼2.0. The aggregation behavior of
the PCA has been compared to the aggregation behav-
ior of two supramolecular systems previously reported,
in which the number of the hydrophobic chains of 18
carbon atoms is one and two, respectively. We inves-
tigated how the shape and the size of the aggregates
is influenced by the number of the hydrophobic chains
[6,7]. As clearly shown in Figure 5 there does not exist
a strong dependence between the hydrophobic portion
and the aggregate shape. There is only an increase of
the ellipticity of the aggregates, as demonstrated by
the comparison of the ratio between the micellar axis,
which moves from 1.0 to 2.0 from the mono tail to
the tetra tail monomers. Moreover, there is a slight
increase of the packing factor as expected. This consid-
eration brings to the conclusion that the aggregation
behavior is not strongly influenced by the hydropho-
bic portion, but it is mainly dictated by the steric and
electrostatic repulsions between the head-groups of the
hydrophilic moiety. The general consideration is that
the steric repulsion due to the contemporary presence
of the peptide and the chelating agent cannot be elim-
inated because they are essential for the activity of
the aggregates as specific and high relaxivity contrast
agent. Instead, there is the possibility to decrease of the
electrostatic repulsion replacing the DTPAGlu chelat-
ing agent, in which there are five negative charges
on the head-group with other chelating agents hav-
ing a minor number of negative charges such as
DOTA, DTPA, DO3A (1,4,7,10-Tetraazacyclododecane-
1,4,7,10-tetracetic acid, diethylenetriaminepentaacetic
acid, 1,4,7,10-tetraazacyclododecane-1,4,7-triaacetic
acid tris(1,1-dimethylethyl) ester). In any case the pres-
ence of the CCK8 bioactive peptide well-exposed on
the external surface of the aggregates yield these kind
of interesting supramolecular compound systems with
application in target selective delivery.
EXPERIMENTAL METHODS
Materials and Methods
Protected Nα-Fmoc-amino acid derivatives, coupling
reagents and Rink-amide MBHA resin were purchased
from Calbiochem-Novabiochem (Laufelfingen, Switzerland).
The Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-AdOO-OH)
was purchased from Neosystem (Strasbourg, France). The
DTPALys-pentaester, N2,N2-bis[2-[bis[2-(1,1-dimethylethoxy)-
2-oxoethyl]-amino]ethyl]-L-lysine 1,1-dimethylethyl Ester and
the N ,N-dioctadecylsuccinamic acid were synthetized accord-
ing to the experimental procedure reported in literature
[20,21]. All other chemicals were commercially available with
Sigma-Aldrich, Fluka (Bucks, Switzerland) or LabScan (Stil-
lorgan, Dublin, Ireland) and were used as received unless
otherwise stated. All solutions were prepared by weight using
doubly distilled water. Samples to be measured by SANS tech-
niques were prepared using heavy water (Sigma-Aldrich, purity
>99.8%). The pH of all solutions was kept constant at 7.4.
Synthesis of (C18)4-(Asp(DTPALys))Lys-L5-G-CCK8
(PCA) Monomer
Peptide synthesis was carried out in solid-phase under stan-
dard conditions using Fmoc strategy [9]. Rink-amide MBHA
resin (0.78 mmol/g, 0.5 mmol scale, 0.640 g) was used. The
peptide chain was elongated by sequential coupling and Fmoc
deprotected for the following Fmoc-amino acid derivatives:
Fmoc-Phe-OH, Fmoc-Asp(OtBu)-OH, Fmoc-Met-OH, Fmoc-
Trp(Boc)-OH, Fmoc-Gly-OH, Fmoc-Met-OH, Fmoc-Tyr(tBu)-
OH, Fmoc-Asp(OtBu)-OH, Fmoc-Gly-OH. All couplings were
performed twice for 1 h, by using an excess of four equiv-
alents for each amino acid derivative. The α-amino acids
were activated in situ by the standard HOBt/benzotriazol-1-yl-
oxy-tris-pyrrolidino-phosphonium (PyBop)/DIPEA procedure.
DMF was used as a solvent. Fmoc deprotections were obtained
by 20% solution of piperidine in DMF. The coupling steps
were monitored by the qualitative Kaiser test. When the pep-
tidic synthesis was complete, the Fmoc N-terminal protecting
group was removed and five residues of Fmoc-AdOO-OH were
condensed by using, for each Fmoc-AdOO-OH residue, an
excess of two equivalents in a single coupling with a reac-
tion time of 60 min under N2 flow at room temperature. After
Fmoc removal from the N-terminal end of the peptide deriva-
tive, 1.248 g (2.0 mmol) of Fmoc-Lys(Mtt)-OH, activated by
one equivalent of PyBop and HOBt and two equivalents of
DIPEA in DMF, were coupled by stirring the slurry suspen-
sion of the resin for 1 h. The solution was filtered and the
resin washed with three portions of DMF and three portions of
DCM. The 4-methyltrityl-protecting group (Mtt) was removed
by treatment with DCM/triisopropylsylane (TIS)/TFA mixture
(94 : 5 : 1). The peptide resin was stirred with 3.0 ml of this
solution for 2 min. The treatment was repeated several times
until the solution became colorless. The resin was washed
three times by DCM and three times by DMF. A residue
of Fmoc-Asp-ODmab (ODmab = 4-{N-[1-(4,4-dimethyl-2,6-
dioxocyclohexylidene)-3-methylbutyl]amino} benzyl alcohol)
was coupled twice under standard conditions on the ε–NH2
of the Lysine. ODmab protecting group was removed from
the Aspartic residue by a 2% Hydrazine in DMF [10]. Com-
plete ODmab removal was checked by UV measurements
(at λ = 290 nm) [12]. Then the DTPALys-pentaester chelat-
ing agent was linked, through its free ε-NH2 amino func-
tion, to the free carboxylic group of the Aspartic residue.
This coupling step was performed using two equivalents
of DTPALys-pentaester and O-(7-azabenzotriazol-1-yl)-1,1,3,3-
tetramethyluronium (HATU), and four equivalents of DIPEA in
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DMF as solvent. The coupling time, compared with the clas-
sical SPPS protocol, was increased up to 2 h and the reaction
was tested for completion by Kaiser test. After removal of the
two N-terminal Fmoc protecting groups 2.488 g (4.0 mmol) of
N ,N-dioctadecylsuccinamic acid in DMF/DCM (1/1) mixture
were condensed. Coupling was repeated twice under N2 flow for
1 h. The liphophilic moiety was activated in situ by the stan-
dard HOBt/PyBop/DIPEA procedure. The peptide derivative
was cleaved from the solid support by suspending the resin
in 10 ml of TFA/TIS/H2O (94.5/2/2.5) mixture of for 12 h.
During this step, all the amino acid side chains and the five
carboxylic groups of DTPALys were simultaneously freed from
their protecting groups. The crude compound was purified
by RP-HPLC. Preparative RP-HPLC was carried out on a Shi-
madzu 8A apparatus equipped with an UV Shimadzu detector
using a Phenomenex (Torrance, CA) C4 column, 22 × 250 mm
with a flow rate of 20 ml min−1. The single peaks were analyzed
by HPLC and mass spectrometry. Analytical RP-HPLC runs
were carried out on a HP Agilent Series 1100 apparatus using
a Phenomenex (Torrance, CA) C18 column, 4.6 × 250 mm with
a flow rate of 1.0 ml min−1. For all the RP-HPLC procedures,
the solvent system used was H2O 0.1% TFA (A) and CH3CN
0.1% TFA (B), with a linear gradient from 5 to 70% B in 30 min
followed by 70 to 95% B in 10 min Mass spectral analysis were
carried out on MALDI-TOF Voyager-DE mass spectrometer
(Perseptive Biosystems) and on ESI ThermoElectron Spec-
trometer (Milan, Italy); in the latter case, a peak at 934 amu,
corresponding to [M + 4H+]/4 was observed. The desired com-
pound [(C18)4-(Asp(DTPALys))Lys-L5-G-CCK8, 180 mg] was
obtained with HPLC; purity higher than 95% with a final
yield of 10%, tR = 15.5 min; MW = 3733 amu.
Preparation of the Solutions
Stock solutions of PCA were prepared in 0.1 M phosphate buffer
at pH 7.4, and filtered through a 0.45 µm filter. Concentrations
of all the solutions were determined by absorbance on a UV-
vis Jasco (Easton, MD) Model 440 spectrophotometer with
a path length of 1 cm using a molar absorptivity (ε280) of
6845 M−1 cm−1 for CCK8. This value was calculated according
to Edelhoch method [22], taking into account the contributions
from tyrosine and tryptophan present in the primary structure,
which amount to 1215 and 5630 M−1 cm−1, respectively [23].
Fluorescence Studies
The cmc values of PCA were obtained by fluorescence spec-
troscopy using 1 cm path length quartz cell. Emission spectra
were recorded at room temperature using a Jasco Model
FP-750 spectrofluorimeter. Equal excitation and emission
bandwidths were used throughout the experiments, with a
recording speed of 125 nm/min and an automatic selection of
the time constant. The cmc of PCA was measured by using
ANS as fluorescent probe. Small aliquots of a self-assembled
aggregate solution (1 · 10−4 M) were added to a fixed volume
of 1 · 10−5 M ANS dissolved in the same buffer. The cmc was
determined by linear least-squares fitting of the fluorescence
emission at 480 nm, upon excitation at 350 nm versus the
amphiphile concentration as previously reported [24,25].
Small-Angle Neutron Scattering (SANS)
SANS measurements were performed at 25 °C, at the LOQ
instrument sited at the ISIS facility of the Rutherford
Appleton Laboratory (Chilton, United Kingdom). At the ISIS
pulsed neutron source, the LOQ instrument uses neutrons of
wavelengths ranging between 2.2 and 10 A˚ detected by a TOF
analysis on a 64 cm2 two-dimensional detector placed at 4.1 m
from the sample [26], giving a q range of 0.006 ÷ 0.24 A˚−1.
Raw data were corrected for wavelength dependent sample
transmissions, incident spectrum, and detector efficiency
and then put into absolute scattering cross sections d/d
by comparison with scattering from a partially deuterated
polystyrene standard.
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